Our unique research approach (e.g., use of 9-TB) will facilitate future investigations into the role of airway epithelial NF-κB in respiratory infections of other strains of bacteria that are relevant to various lung diseases such as asthma, COPD and cystic fibrosis. This evidence concerns the gene NFKB1 and chronic obstructive pulmonary disease.